{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:04:57Z","timestamp":1790057097660,"version":"4.0.1"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypoxia, cancer stem cell (CSC) plasticity, and immune suppression are established features of the tumor microenvironment, but their integration within the same biological systems has not been comprehensively synthesized. This systematic review evaluated whether hypoxia or hypoxia-associated signaling coordinates CSC or stemness phenotypes with immune-related mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, Embase, Scopus, Web of Science, and Google Scholar were searched for English-language studies published from 1 January 2010 to 31 January 2026. Eligible studies were required to evaluate hypoxia or hypoxia-associated signaling, CSC or stemness phenotypes, and immune-related outcomes within the same experimental or translational study. Of 1,569 records identified, 39 reports underwent full-text assessment and 14 studies were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Hypoxia-associated conditions were recurrently linked to CSC enrichment, self-renewal, epithelial-to-mesenchymal transition, tumorigenicity, metastatic potential, immune suppression, and therapeutic resistance. Four context-dependent patterns emerged: impaired natural killer, cytokine-induced killer, and CD8-positive T-cell function; myeloid- and macrophage-mediated reinforcement of CSC states through polarization, cytokine signaling, extracellular vesicles, cellular transfer, and stromal or vascular remodeling; checkpoint-associated and adaptive immune suppression involving PD-L1, CD47, regulatory T cells, and myeloid-derived suppressor cells; and an integrated hypoxic CSC\u2013immune niche phenotype. Preclinical intervention studies indicated that selected pathways may be therapeutically modifiable, although the evidence remained predominantly experimental.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Hypoxia appears to act as a coordinating microenvironmental pressure linking CSC plasticity with immune dysfunction in selected tumor contexts. The proposed hypoxic CSC\u2013immune niche is a mechanistic framework rather than evidence of a universal pathway and requires validation using spatially resolved human tumors, patient-derived immune models, and treatment-response-linked cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420261287704<\/jats:ext-link>\n                      , identifier CRD420261287704.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1942424","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:39:39Z","timestamp":1790055579000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypoxic cancer stem cell\u2013immune niches in the tumor microenvironment: a Systematic Review of mechanisms and therapeutic implications"],"prefix":"10.3389","volume":"17","author":[{"given":"Prasanna","family":"Appiya Premvignesh","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, College of Medicine, Gulf Medical University","place":["Ajman, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abubakker Siddiq","family":"Mohamed Hameed","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Medical University of Lublin","place":["Lublin, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Mustufa Topiwala","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Medical University of Lublin","place":["Lublin, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Nayeem","family":"Shaji","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Medical University of Lublin","place":["Lublin, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latifa","family":"Alsaad","sequence":"additional","affiliation":[{"name":"Research and Graduate Studies, Mohammed Bin Rashid University of Medicine and Health Sciences","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safaa Mahmoud","family":"Mohamed Abdelkhalek","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, College of Medicine, Gulf Medical University","place":["Ajman, United Arab Emirates"]},{"name":"Department of Pathology, Faculty of Medicine, Ain Shams University","place":["Cairo, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazeerullah","family":"Rahamathullah","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, College of Medicine, Gulf Medical University","place":["Ajman, United Arab Emirates"]},{"name":"Thumbay Research Institute for Precision Medicine, Gulf Medical University","place":["Ajman, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salem","family":"Chouaib","sequence":"additional","affiliation":[{"name":"Thumbay Research Institute for Precision Medicine, Gulf Medical University","place":["Ajman, United Arab Emirates"]},{"name":"INSERM UMR 1186, Integrative Tumor Immunology and Cancer Immunotherapy, Gustave Roussy, University Paris-Saclay","place":["Villejuif, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12935-020-01719-5","article-title":"The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment","volume":"21","author":"Emami Nejad","year":"2021","journal-title":"Cancer Cell Int"},{"key":"B2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s00018-024-05537-0","article-title":"HIF-1 and HIF-2 in cancer: structure, regulation, and therapeutic prospects","volume":"82","author":"Shi","year":"2025","journal-title":"Cell Mol Life Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpt.2025.07.003","article-title":"Investigating hypoxia-inducible factor signaling in cancer: mechanisms, clinical implications, targeted therapeutic strategies, and resistance","volume":"4","author":"Shaikat","year":"2025","journal-title":"Cancer Pathog Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/cells14070538","article-title":"Stem cells in cancer: from mechanisms to therapeutic strategies","volume":"14","author":"Haddadin","year":"2025","journal-title":"Cells"},{"key":"B6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-025-02360-2","article-title":"Cancer stem cells: landscape, challenges and emerging therapeutic innovations","volume":"10","author":"Lee","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1227884","article-title":"Hypoxia-induced cancer cell reprogramming: a review on how cancer stem cells arise","volume":"13","author":"Abd","year":"2023","journal-title":"Front Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12943-022-01682-x","article-title":"Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis","volume":"21","author":"Nallasamy","year":"2022","journal-title":"Mol Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13287-022-02904-1","article-title":"Characteristics of the cancer stem cell niche and therapeutic strategies","volume":"13","author":"Ju","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"B10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13045-025-01684-4","article-title":"Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance","volume":"18","author":"Shang","year":"2025","journal-title":"J Hematol Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.120057","article-title":"The impact of hypoxia on immune state in cancer","volume":"286","author":"Mortezaee","year":"2021","journal-title":"Life Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13045-022-01292-6","article-title":"Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape","volume":"15","author":"Wu","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s43046-023-00186-z","article-title":"Mechanisms of HIF-driven immunosuppression in tumour microenvironment","volume":"35","author":"Bandopadhyay","year":"2023","journal-title":"J Egypt Natl Canc Inst"},{"key":"B14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12943-025-02265-2","article-title":"Cancer stem cells and niches: challenges in immunotherapy resistance","volume":"24","author":"Pan","year":"2025","journal-title":"Mol Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2023.11.008","article-title":"Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: impact on cancer immunotherapy","volume":"97","author":"Abou Khouzam","year":"2023","journal-title":"Semin Cancer Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE's risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"B18","unstructured":"Newcastle-Ottawa Scale (Nos)\n          \n          2025"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009621","article-title":"Frizzled-7-targeting antibody-derived bifunctional protein retargets NK cells against triple-negative breast cancer cells via MICA-NKG2D axis","volume":"13","author":"Wang","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113535","article-title":"Co-Colorectal cancer stem cells employ the FADS1\/DDA axis to evade NK cell-mediated immunosuppression after co-cultured with NK cells under hypoxia","volume":"143","author":"Geng","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2019.4794","article-title":"Epithelial ovarian cancer stem-like cells are resistant to the cellular lysis of cytokine-induced killer cells via HIF1A-mediated downregulation of ICAM-1","volume":"55","author":"Bu","year":"2019","journal-title":"Int J Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsw040","article-title":"Altered CD8+ T-cell lymphocyte function and TC1 cell stemness contribute to enhanced Malignant tumor properties in murine models of sleep apnea","volume":"40","author":"Akbarpour","year":"2017","journal-title":"Sleep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216801","article-title":"Hypoxia-induced TREM1 promotes mesenchymal-like states of glioma stem cells via alternatively activating tumor-associated macrophages","volume":"590","author":"Dong","year":"2024","journal-title":"Cancer Lett"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-2374","article-title":"The immunosuppressive microenvironment in BRCA1-IRIS-overexpressing TNBC tumors is induced by bidirectional interaction with tumor-associated macrophages","volume":"80","author":"Sami","year":"2020","journal-title":"Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/cns.13892","article-title":"Hypoxia-induced polypoid giant cancer cells in glioma promote the transformation of tumor-associated macrophages to a tumor-supportive phenotype","volume":"28","author":"Liu","year":"2022","journal-title":"CNS Neurosci Ther"},{"key":"B27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.molimm.2025.08.022","article-title":"SNHG16-loaded extracellular vesicles from hypoxic NSCLC cells drive M2 macrophage polarization to enhance cancer aggressiveness","volume":"187","author":"Hou","year":"2025","journal-title":"Mol Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41525-022-00333-w","article-title":"Direct cell-to-cell transfer in stressed tumor microenvironment aggravates tumorigenic or metastatic potential in pancreatic cancer","volume":"7","author":"Jang","year":"2022","journal-title":"NPJ Genom Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12828","article-title":"TGFBI modulates tumour hypoxia and promotes breast cancer metastasis","volume":"14","author":"Fico","year":"2020","journal-title":"Mol Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302140","article-title":"Cutting edge: Hypoxia-induced Nanog favors the intratumoral infiltration of regulatory T cells and macrophages via direct regulation of TGF-\u03b21","volume":"191","author":"Hasmim","year":"2013","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2701023","article-title":"Increased expression of PD-L1 in endometrial cancer stem-like cells is regulated by hypoxia","volume":"27","author":"Yin","year":"2022","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123094","article-title":"A mitochondria-interfering nanocomplex cooperates with photodynamic therapy to boost antitumor immunity","volume":"317","author":"Zhang","year":"2025","journal-title":"Biomaterials"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adr8001","article-title":"Pulsatile sequential drug release system for cascade tumor deep penetration and differentiation therapy to enhance chemoimmunotherapy","volume":"11","author":"Liu","year":"2025","journal-title":"Sci Adv"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2021.10.002","article-title":"Hypoxia signaling: challenges and opportunities for cancer therapy","volume":"85","author":"Ivan","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/cells10030678","article-title":"Hypoxia-driven effects in cancer: characterization, mechanisms, and therapeutic implications","volume":"10","author":"Shi","year":"2021","journal-title":"Cells"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/cells14060403","article-title":"Cross-talk between cancer and its cellular environment-a role in cancer progression","volume":"14","author":"Turlej","year":"2025","journal-title":"Cells"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1942424\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:39:42Z","timestamp":1790055582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1942424\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2026.1942424"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1942424","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"article-number":"1942424"}}